Advanced Filters
noise

Plainville, Connecticut Clinical Trials

A listing of Plainville, Connecticut clinical trials actively recruiting patient volunteers.

Found 84 clinical trials
L Lauren C Schmidtberg

Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty

The goal of this randomized control trial is to in [describe participant population/health conditions]. The main question it aims to answer is: • Is the use of intraoperative subpectoral bupivacaine associated with decreased post-operative pain in adolescent patients who undergo bilateral reduction mammaplasty Participants will be randomized into the study …

13 - 25 years of age All Phase 4
K Katie E Boyle, MPH

Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

The rationale for fetal therapy in severe congenital diaphragmatic hernia (CDH) is to restore adequate lung growth for neonatal survival.

18 years of age Female Phase N/A
N Natasha Frederick, MD, MPH

Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention

The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to improve adolescent and young adult (AYA)- clinician sexual and reproductive health (SRH) communication in the outpatient oncology clinic setting.

15 - 25 years of age All Phase N/A
L Lisa Kenyon-Pesce, MPH

Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome

The goal of this clinical trial is to test the effect of a supplement called MitoQ (mitoquinol mesylate) on bladder symptoms such as urgency and frequency in women 50 years and older who have the metabolic syndrome. The main questions it aims to answer are: Is the study design feasible …

50 years of age Female Phase 2

rTMS as Add on Treatment for Substance Use Disorders

This pilot study is designed to test feasibility and superiority of rTMS types and target locations for the optimal rTMS intervention for individuals seeking treatment for Alcohol Use Disorder (AUD) or Opioid Use Disorder (OUD). The critical questions this study seeks to answer are: which rTMS type applied to l-dlPFC …

18 - 60 years of age All Phase N/A
L Lawrence Engmann, M.D., M.R.C.O.G

A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence

This research is being done to determine if producing sperm after an ultrashort period of abstinence (1 hour of abstinence) will be effective in improving the rates of embryos with normal chromosomes (structures that carry genetic information) during in vitro fertilization (IVF) treatment. The investigators hypothesize that a shorter period …

18 - 42 years of age All Phase N/A
K Karen L Kesten, MS

Target ADHD Executive Working Memory Replication Study

The proposed study will replicate target engagement as assessed in the first phase while also determining if it correlates with clinically meaningful improvements in ADHD dysfunction

12 - 18 years of age All Phase N/A
J Jimmy Choi, PsyD

Improving Availability of Intranasal Naloxone

While there is a lifesaving medication called naloxone that can reverse the deadly effects of opioid overdose, patients often fail to fill the prescription at the pharmacy when it is prescribed. This is particularly concerning and true in those at the highest risk of death-those who end up in the …

21 - 65 years of age All Phase N/A

Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)

This study will evaluate the efficacy and safety of Gadopiclenol, an FDA-approved contrast agent, for visualizing pituitary lesions on MR images by comparing with the comparator, Gadobutrol, a clinically widely used contrast agent. The study is double-blinded, so neither the participants nor the researchers know which contrast agent is being …

19 years of age All Phase 4
A Alexandra W Abry, BA

Integrated Treatment for Enhancing Growth in Recovery During Adolescence

This is a Phase II parallel group randomized controlled trial with 294 adolescents (age: 14-21 years) with alcohol and other drug [AOD] use disorder (hereafter substance use disorder), that compares two different active psychosocial interventions designed to address adolescent substance use disorder. Participants are recruited from our clinical settings and …

14 - 21 years of age All Phase N/A

Simplify language using AI